ATNF logo

180 Life Sciences (ATNF) Cash From Operations

ATNF Annual CFO

-$10.92 M
+$1.21 M+9.94%

31 December 2023

ATNF Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ATNF Quarterly CFO

-$223.70 K
-$950.90 K-130.76%

30 September 2024

ATNF Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ATNF TTM CFO

-$2.69 M
+$1.55 M+36.58%

30 September 2024

ATNF TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ATNF Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.9%+78.3%+66.7%
3 y3 years-182.1%+94.2%+80.7%
5 y5 years-229.1%+94.2%+80.7%

ATNF Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+43.6%-130.8%+95.5%at high+86.1%
5 y5-year-229.1%+43.6%-130.8%+96.5%-557.7%+86.1%
alltimeall time-229.1%+43.6%-130.8%+96.5%-557.7%+86.1%

180 Life Sciences Cash From Operations History

DateAnnualQuarterlyTTM
Sept 2024
-
-$223.70 K(-130.8%)
-$2.69 M(-36.6%)
June 2024
-
$727.20 K(-170.4%)
-$4.24 M(-47.5%)
Mar 2024
-
-$1.03 M(-52.2%)
-$8.09 M(-26.0%)
Dec 2023
-$10.92 M(-9.9%)
-$2.16 M(+21.7%)
-$10.92 M(-6.6%)
Sept 2023
-
-$1.78 M(-43.0%)
-$11.69 M(-13.5%)
June 2023
-
-$3.12 M(-19.5%)
-$13.51 M(-3.0%)
Mar 2023
-
-$3.87 M(+32.2%)
-$13.92 M(+14.8%)
Dec 2022
-$12.13 M
-$2.93 M(-18.6%)
-$12.13 M(-14.8%)
Sept 2022
-
-$3.60 M(+1.8%)
-$14.23 M(-2.8%)
June 2022
-
-$3.53 M(+70.4%)
-$14.63 M(-3.2%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$2.07 M(-58.8%)
-$15.11 M(-22.0%)
Dec 2021
-$19.37 M(+400.3%)
-$5.03 M(+25.6%)
-$19.37 M(+10.3%)
Sept 2021
-
-$4.00 M(-0.2%)
-$17.56 M(+29.0%)
June 2021
-
-$4.01 M(-36.6%)
-$13.61 M(+39.0%)
Mar 2021
-
-$6.33 M(+96.8%)
-$9.79 M(+152.9%)
Dec 2020
-$3.87 M(+16.7%)
-$3.22 M(+5856.3%)
-$3.87 M(+490.6%)
Sept 2020
-
-$54.00 K(-72.0%)
-$655.60 K(+9.0%)
June 2020
-
-$192.60 K(-52.9%)
-$601.60 K(+47.1%)
Mar 2020
-
-$409.00 K
-$409.00 K
Dec 2019
-$3.32 M
-
-

FAQ

  • What is 180 Life Sciences annual cash flow from operations?
  • What is the all time high annual CFO for 180 Life Sciences?
  • What is 180 Life Sciences annual CFO year-on-year change?
  • What is 180 Life Sciences quarterly cash flow from operations?
  • What is the all time high quarterly CFO for 180 Life Sciences?
  • What is 180 Life Sciences quarterly CFO year-on-year change?
  • What is 180 Life Sciences TTM cash flow from operations?
  • What is the all time high TTM CFO for 180 Life Sciences?
  • What is 180 Life Sciences TTM CFO year-on-year change?

What is 180 Life Sciences annual cash flow from operations?

The current annual CFO of ATNF is -$10.92 M

What is the all time high annual CFO for 180 Life Sciences?

180 Life Sciences all-time high annual cash flow from operations is -$3.32 M

What is 180 Life Sciences annual CFO year-on-year change?

Over the past year, ATNF annual cash flow from operations has changed by +$1.21 M (+9.94%)

What is 180 Life Sciences quarterly cash flow from operations?

The current quarterly CFO of ATNF is -$223.70 K

What is the all time high quarterly CFO for 180 Life Sciences?

180 Life Sciences all-time high quarterly cash flow from operations is $727.20 K

What is 180 Life Sciences quarterly CFO year-on-year change?

Over the past year, ATNF quarterly cash flow from operations has changed by +$809.70 K (+78.35%)

What is 180 Life Sciences TTM cash flow from operations?

The current TTM CFO of ATNF is -$2.69 M

What is the all time high TTM CFO for 180 Life Sciences?

180 Life Sciences all-time high TTM cash flow from operations is -$409.00 K

What is 180 Life Sciences TTM CFO year-on-year change?

Over the past year, ATNF TTM cash flow from operations has changed by +$5.40 M (+66.73%)